ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2014, Vol. 23 ›› Issue (5): 437-442.

• 论文 • 上一篇    下一篇

两种新型连续性肾脏替代治疗模式对溶质清除的影响

  

  • 出版日期:2014-10-28 发布日期:2014-11-03

Clearance of different solutes by two novel modes of continuous renal replacement therapy: a prospective randomized controlled study

  • Online:2014-10-28 Published:2014-11-03

摘要:

目的:本研究设计两种新型连续性肾脏替代治疗(CRRT)模式,并探讨其对不同分子量溶质的清除率。
方法: 2013年9月至2014年2月期间南京军区南京总医院医院需接受长时血液透析的患者40例,随机分为4组,每组10例。分别接受标准剂量的血液滤过(SVHF)、高容量血液滤过(HVHF)、双重血液滤过(double hemofiltration,DHF)、无透析液的血液透析滤过(dialysate-free hemdiafitration,DF-HDF)治疗。四种治疗模式废液流量分别为35ml/Kg/h、100ml/Kg/h、35ml/Kg/h、30ml/Kg/h。治疗1小时时分别留取血液和废液标本,计算肌酐、β2-微球蛋白、磷、胱抑素C、叶酸、同型半胱氨酸、微量元素等溶质的清除率。
结果:SVHF组、HVHF组、DHF组、DF-HDF组肌酐清除率分别为30.1±2.0ml/Kg/h、69.0±7.2ml/Kg/h、32.3±4.2ml/Kg/h、32.1±3.4ml/Kg/h,DHF组及DF-HDF组的肌酐清除率明显低于HVHF组清除率(P<0.05),不高于SVHF组。SVHF组、HVHF组、DHF组、DF-HDF组的β2-微球蛋白清除率分别为16.1±2.8ml/Kg/h、35.0±7.5ml/Kg/h、40.8±9.9ml/Kg/h、35.8±10.6 ml/Kg/h,DHF组及DF-HDF组的β2-微球蛋白清除率不低于HVHF组清除率,但明显高于SVHF组清除率(P<0.05)。治疗时患者无严重不良反应。
结论:DHF及DF-HDF相比HVHF明显减少了小分子溶质的清除,相比SVHF增加了中分子溶质的清除,为临床开展应用新技术建立理论基础。

关键词:  双重血液滤过, 无透析液的血液透析滤过, 高容量血液滤过, 清除率, 中分子溶质

Abstract:

ABSTRACT objective: To design two novel modes of continuous renal replacement therapy (CRRT) and compare the capability of clearance of solutes by two ways of CRRT. Methodology: Forty patients with renal failure receiving extended hemodialysis were enrolled into this prospective randomized controlled study from September 2013 to Febrary 2014. They were randomly divided into four groups (each group, n=10): standard volume hemfiltration (SVHF), HVHF, double hemofiltration (DHF) or dialysate-free hemodiafiltration (DF-HDF). The effulent fluid in four groups were 35ml/(kg.h), 100ml/(kg.h), 35ml/Kg/h and 30ml/(kg.h), respectively. The specimens of blood and effulent fluid were collected at the first hour after start of blood purification, and the clearances of β2-microglobunlin, cystatin C, creatinine, trace element, hemocyseine and other solutes were calculated. Results: They were 21 males and 19 females with a mean age of 44.8 years old. The clearance of creatinine by SVHF, HVHF, DHF, DF-HDF were 30.1±2.0ml/(kg.h), 69.0±7.2ml/(kg.h), 32.3±4.2ml/(kg.h), 32.1±3.4ml/(kg.h), respectively, and the clearance of creatinine by DHF, DF-HDF were significantly inferior to that of HVHF (P<0.05) and not superior to that of SVHF. The clearance of β2-microglobunlin by SVHF, HVHF, DHF, DF-HDF were 16.1±2.8ml/Kg/h, 35.0±7.5ml/(kg.h), 40.8±9.9ml/(kg.h), 35.8±10.6 ml/(kg.h), respectively, and the clearance of β2-microglobunlin by DHF, DF-HDF were not inferior to that of HVHF and were superior to that of SVHF (P<0.05). No severe adverse effects were observed in the duration of treatment. Conclusion: DHF and DF-HDF increase the removal of middle molecular solutes compared to SVHF and decrease the removal of small soluble solutes compared to HVHF.

Key words: double hemofiltration, dialysate-free hemodiafiltration, high volume hemofiltration, clearance, middle molecular solutes